These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2522 related items for PubMed ID: 26576089

  • 21. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J, Huang HL, Li J, Qian FC, Li LQ, Niu PP, Dai LC.
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [Abstract] [Full Text] [Related]

  • 22. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.
    Lorenzer C, Dirin M, Winkler AM, Baumann V, Winkler J.
    J Control Release; 2015 Apr 10; 203():1-15. PubMed ID: 25660205
    [Abstract] [Full Text] [Related]

  • 23. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ, Yook S, Yhee JY, Yoon HY, Kim MG, Ku SH, Kim SH, Park JH, Jeong JH, Kwon IC, Lee S, Lee H, Kim K.
    J Control Release; 2015 Dec 28; 220(Pt B):631-41. PubMed ID: 26307351
    [Abstract] [Full Text] [Related]

  • 24. Nonviral pulmonary delivery of siRNA.
    Merkel OM, Kissel T.
    Acc Chem Res; 2012 Jul 17; 45(7):961-70. PubMed ID: 21905687
    [Abstract] [Full Text] [Related]

  • 25. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E, Oba T, Lin J, Shao R, Meng F, Cao X, Lin HY, Mourad M, Pataer A, Baladandayuthapani V, Cai D, Roth JA, Ji L.
    Oncotarget; 2017 Jul 18; 8(29):48222-48239. PubMed ID: 28637023
    [Abstract] [Full Text] [Related]

  • 26. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B, Du HJ, Yan GP, Zhuo RX, Wu Y, Fan CL.
    Drug Deliv; 2014 May 18; 21(3):204-12. PubMed ID: 24117028
    [Abstract] [Full Text] [Related]

  • 27. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
    Scarabel L, Perrone F, Garziera M, Farra R, Grassi M, Musiani F, Russo Spena C, Salis B, De Stefano L, Toffoli G, Rizzolio F, Tonon F, Abrami M, Chiarappa G, Pozzato G, Forte G, Grassi G, Dapas B.
    Expert Opin Drug Deliv; 2017 Jun 18; 14(6):797-810. PubMed ID: 28266887
    [Abstract] [Full Text] [Related]

  • 28. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy.
    Shen S, Sun CY, Du XJ, Li HJ, Liu Y, Xia JX, Zhu YH, Wang J.
    Biomaterials; 2015 Nov 18; 70():71-83. PubMed ID: 26302232
    [Abstract] [Full Text] [Related]

  • 29. Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.
    Zheng G, Zhao R, Xu A, Shen Z, Chen X, Shao J.
    Eur J Pharm Sci; 2018 Jan 01; 111():492-502. PubMed ID: 29107835
    [Abstract] [Full Text] [Related]

  • 30. pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery.
    Zhu H, Zhang S, Ling Y, Meng G, Yang Y, Zhang W.
    J Control Release; 2015 Dec 28; 220(Pt A):529-544. PubMed ID: 26590349
    [Abstract] [Full Text] [Related]

  • 31. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y, Guo CG, Yang ZG, Sun JH, Zhang MM, Fu CY.
    Drug Des Devel Ther; 2016 Dec 28; 10():1243-55. PubMed ID: 27069355
    [Abstract] [Full Text] [Related]

  • 32. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
    Rajasekaran D, Srivastava J, Ebeid K, Gredler R, Akiel M, Jariwala N, Robertson CL, Shen XN, Siddiq A, Fisher PB, Salem AK, Sarkar D.
    Bioconjug Chem; 2015 Aug 19; 26(8):1651-61. PubMed ID: 26079152
    [Abstract] [Full Text] [Related]

  • 33. Targeted Liposomes for siRNA Delivery to Cancer.
    Eloy JO, Petrilli R, Raspantini GL, Lee RJ.
    Curr Pharm Des; 2018 Aug 19; 24(23):2664-2672. PubMed ID: 30084323
    [Abstract] [Full Text] [Related]

  • 34. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
    Han L, Tang C, Yin C.
    Biomaterials; 2014 May 19; 35(15):4589-600. PubMed ID: 24613049
    [Abstract] [Full Text] [Related]

  • 35. Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.
    Varshosaz J, Vakilzadeh H, Ghassami E.
    Curr Pharm Des; 2016 May 19; 22(22):3466-85. PubMed ID: 26861646
    [Abstract] [Full Text] [Related]

  • 36. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
    Xia Y, Guo M, Xu T, Li Y, Wang C, Lin Z, Zhao M, Zhu B.
    Int J Nanomedicine; 2018 May 19; 13():1539-1552. PubMed ID: 29588583
    [Abstract] [Full Text] [Related]

  • 37. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.
    Lu J, Wang J, Ling D.
    Small; 2018 Feb 19; 14(5):. PubMed ID: 29251419
    [Abstract] [Full Text] [Related]

  • 38. Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy.
    Qu Y, Sun F, He F, Yu C, Lv J, Zhang Q, Liang D, Yu C, Wang J, Zhang X, Xu A, Wu J.
    Eur J Pharm Sci; 2019 Nov 01; 139():105036. PubMed ID: 31446078
    [Abstract] [Full Text] [Related]

  • 39. Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer.
    Hong SS, Zhang MX, Zhang M, Yu Y, Chen J, Zhang XY, Xu CJ.
    Drug Deliv; 2018 Nov 01; 25(1):576-584. PubMed ID: 29461120
    [Abstract] [Full Text] [Related]

  • 40. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X.
    Eur J Pharm Biopharm; 2015 Jun 01; 93():27-36. PubMed ID: 25770771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 127.